<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Modern Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Modern Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Современная онкология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1815-1434</issn><issn publication-format="electronic">1815-1442</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">26498</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Rak mochevogo puzyrya</article-title><trans-title-group xml:lang="ru"><trans-title>Рак мочевого пузыря</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Figurin</surname><given-names>K M</given-names></name><name xml:lang="ru"><surname>Фигурин</surname><given-names>К М</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Российский онкологический научный центр им. Н.Н.Блохина РАМН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2003-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2003</year></pub-date><volume>5</volume><issue>2</issue><issue-title xml:lang="en">VOL 5, NO2 (2003)</issue-title><issue-title xml:lang="ru">ТОМ 5, №2 (2003)</issue-title><fpage>59</fpage><lpage>62</lpage><history><date date-type="received" iso-8601-date="2020-04-09"><day>09</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2003, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2003, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2003</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://modernonco.orscience.ru/1815-1434/article/view/26498">https://modernonco.orscience.ru/1815-1434/article/view/26498</self-uri><abstract xml:lang="ru"><p>ак мочевого пузыря (РМП) в 2000 г. занимал в структуре онкологической заболеваемости населения России 8-е место у мужчин и 17-18-е место у женщин. Широкое применение при инвазивном и диссеминированном РМП нашла системная химиотерапия. лечение по схеме гемзар + цисплатин оказалось более безопасным и столь же эффективным, как и режим MVAC. Комбинацию GC можно использовать при местно-распространенном и диссеминированном переходноклеточном РМП в качестве стандартного лечения.</p></abstract></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Давыдов М.И., Аксель Е.М. Злокачественные новообразования в России и странах СНГ в 2000 г. М., 2002.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>"TNM classification of malignant tumours" Ed. by L.H. Sobin and Ch Wittekind. Fifth edition, 1997; Wiley-Liss, New York...,p. 187-90.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Boman H, Hedelin H., Jacobsson S, Holmdng S.J. Urol 2002; 168 (5): 1955.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Кудашев Б.В. Автореф. дисс.... канд. мед. наук.М., 2001.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Öosterlinck W, Lobel B., Jakse G. et al, Europ Urol 2002; 41 (2): 105-12.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Матвеев В.Н., Кудашев В.В., Бухаркин Б.В. и др. Урология, 2000; 3:22-4.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Lamm D.L. Anti-Cancer Drugs 1992; 3(1): 39-47</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Tolley D.A, Parmar M.K.B, Grigor K.M. Lallemand G. and the Medical research council superficial bladder cancer working party. J Urol 1996; 155 (4): 1233-8.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Матвеев Б.П., Фигурин K.M., Романов В.А., Чебан Н.Л. Урол. и нефрол. 1995; 5:35-7.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Sylvester R., van der Meijden А.Р.М, Lamm D.L. J Urol 2002; 168 (5): 1964-70.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Glashan R.W. f Urol 1990; 144: 658-61.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Русаков И.Г. Симпозиум "Современные подходы к лечению онкоурологическихзаболеваний".М., 26мая 1998; Тезисы докладов. С. 8-11.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Алексеев Б.Я. Автореф. дисс.... канд.мед. наук.М., 1998.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Dalbagni G, Russo Р, Sheinfeld J. et al. J Clin Oncol 2002; 20:3193-8.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Witjes W.P.J, Kimig M. Boeminghaus F.P. et al. European Urology 1999; 35 (6): 576-81.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Waidelich R, Stepp H, Baumgartner R. et al. J Urol 2001; 165 (6.part 1 of 2): 1904-7.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17- Фигурин К.М, Матвеев В.Н., Матвеев В.В. и др. VI ежегодная Российская онкологическая конференция. 26-28 ноября 2002. С 103-6.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Pollera C.F, Ceribelli A, Crecco М et cd. Ann Oncol 1994; 5: 182-4.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>De Lena M, Gridelli С. Lorusso Vet cd. Proc Am Soc Clin Oncol 1996; 15:246.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Stadler W.M, Kuzel T.M, Roth B et cd.J C lin Oncol 1997; 15:3394-8. 21.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Moore M., Tannockl F, Ernst D.S. et al.J C lin Oncol 1997; 15:3441-5</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Kaufman D, Stadler W, Carducci M. et al. Proc Am Soc Clin Oncol 1998; 17: 320a, abstract 1235</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Mancarella S, Lorusso V, Manzione L et al. Eur J Cancer 1999; 35 (suppl. 4): S347, abstract 1405</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Moore J.M, Winquist E.W, Murray N et al. C lin Oncol 1999; 17: 2876-81.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Von derMaase H, Hansen S.W, Roberts J.T. et. al.J Clin Oncol 2000; 17: 3068-77.</mixed-citation></ref></ref-list></back></article>
